Better Biomarkers Mean Better Research
At the Early Clinical Trial Development Conference in Philadelphia, representatives from multiple pharma companies and CROs discussed the need for biomarker research at earlier stages of the trial process.
Why are studies on biomarkers so important? Because they give us a road map for better, more cost-effective treatments.
- Biomarkers help us find better drug targets and lets pharma companies focus their time and money on treatments that work.
- Biomarkers show us how new therapies affect a disease’s progression. That lets developers look at drug efficacy through all stages of treatment.
Biomarker research helps focus a study’s objectives and establish earlier ‘kill-times’ for ineffective treatments. That could save millions on drug development and testing.